We are live on ! Find out more
LAB icon

Standard BioTools
LAB

135 hedge funds and large institutions have $864M invested in Standard BioTools in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

26% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 43

8.48% more ownership

Funds ownership: 93.19% → 101.67% (+8.5%)

3% more funds holding

Funds holding: 131 → 135 (+4)

1% more capital invested

Capital invested by funds: $854M → $864M (+$10.1M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

97% less call options, than puts

Call options by funds: $6K | Put options by funds: $196K

Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
29
Increased
54
Reduced
43
Closed
23
Calls
$6K
Puts
$196K
Net Calls
-$190K
Net Calls Change
-$452K

Top Buyers

1
BlackRock
BlackRock
New York
+$29.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21.8M
3
Morgan Stanley
Morgan Stanley
New York
+$19M
4
N
Nuveen
North Carolina
+$14.3M
5
State Street
State Street
Massachusetts
+$9.18M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$18.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$10.7M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$9.3M
4
SSA
Schonfeld Strategic Advisors
New York
-$7.08M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
51
Royce & Associates
New York
$2.28M – – –
BIM
52
Bogle Investment Management
Massachusetts
$2.23M -$92.1K -7,228 -4%
SEI Investments
53
SEI Investments
Pennsylvania
$2.22M +$326K +25,627 +17%
Squarepoint
54
Squarepoint
New York
$2.2M +$751K +58,992 +49%
LCS
55
Levin Capital Strategies
New York
$2.15M -$81.9K -6,427 -4%
Charles Schwab
56
Charles Schwab
California
$2.02M +$995K +78,104 +91%
AR
57
Advisory Research
Illinois
$2.02M +$1.17M +91,965 +127%
QI
58
QS Investors
New York
$2M +$2.07M +162,300 New
IP
59
Intellectus Partners
California
$1.95M -$38.2K -3,000 -2%
EGM
60
Engineers Gate Manager
New York
$1.66M +$295K +23,132 +21%
Swiss National Bank
61
Swiss National Bank
Switzerland
$1.58M +$1.63M +128,300 New
PPA
62
Parametric Portfolio Associates
Washington
$1.56M -$207K -16,257 -11%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$1.49M +$596K +46,800 +63%
CEP
64
Chicago Equity Partners
Illinois
$1.44M -$1.13M -88,790 -43%
CS
65
Credit Suisse
Switzerland
$1.43M +$1.48M +116,042 New
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$1.37M +$642K +50,405 +83%
WMSA
67
Weiss Multi-Strategy Advisers
New York
$1.35M -$127K -10,000 -8%
HSBC Holdings
68
HSBC Holdings
United Kingdom
$1.32M +$1.37M +107,183 New
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$1.31M +$708K +55,563 +109%
Assenagon Asset Management
70
Assenagon Asset Management
Luxembourg
$1.3M +$1.34M +105,400 New
CIP
71
Chartwell Investment Partners
Pennsylvania
$1.22M +$1.26M +98,631 New
EGI
72
EAM Global Investors
California
$1.18M -$809K -63,539 -40%
JP Morgan Chase
73
JP Morgan Chase
New York
$1.18M -$367K -28,775 -23%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$1.04M +$554K +43,507 +107%
PP
75
PDT Partners
New York
$922K +$484 +38 +0.1%
1 2
3
4 5

LAB Hedge Fund Activity: Q2 2019 in Review

135 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2019, worth a combined $864M — up 1.2% from $854M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 23 closed out — a net gain of 6 holders — while 54 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock, adding an estimated $29.2M. The largest seller was Easterly Investment Partners, cutting an estimated $18.2M.

  • 135 institutional investors held Standard BioTools (LAB) as of Q2 2019, up from 131 in Q1 2019.
  • Funds reported $864M of Standard BioTools stock for Q2 2019, up 1.2% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2019 and 23 closed out, a net change of +6 holders.
  • The largest Standard BioTools buyer in Q2 2019 was BlackRock, an estimated $29.2M added.
  • The largest Standard BioTools seller in Q2 2019 was Easterly Investment Partners, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2019.